Bicara Therapeutics Logo (full size)
Bicara Therapeutics Logo icon/symbol
Bicara Therapeutics Logo (full size) on a dark background
Bicara Therapeutics Logo icon/symbol on a dark background
About Bicara Therapeutics
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
September 19th, 2024
